(from the article `Economic Affairs`) ...faced other challenges, including the fact that its top-selling drug, Zocor, would become available as a generic in 2006. Other drugmakers faced ... ...however, that COX-2 inhibitors (which are also NSAIDs) offered superior relief of pain or inflammation. Of the two other COX-2 inhibitors on the ...
Found on
http://www.britannica.com/eb/a-z/b/58
NOTE: April 7, 2005, Pfizer agreed to suspend sales and marketing of Bextra in the U.S., pending further discussions with the with the FDA. For more information, please read the FDA press release. Bextra: Brand name for valdecoxib, a nonsteroidal anti-inflammatory drugs (NSAID) that inhibits cox-2, an enzyme that makes prostaglandins which promote ...
Found on
http://www.medterms.com/script/main/art.asp?articlekey=40010
No exact match found.
